portal
  Home About us Reports Charts News Custom Company Scan  
Report Charts News
*
Title Content
Economy&Goods
  Economy
  ConsumerGoods
  Food&Beverage
  Agriculture
Life Sciences
  Biotechnology
  Medical
  Pharmaceutical
Manufacturing
  Automotive
  Chemical
  Energy
  Machinery
  Material
  Metals & Minerals
Public Sector
  Environment
  Finance Service
  Infrastructure
  Logistics
  Real Estate
  Retailing
  Tourism
  Training
Technology And Media
  Electronics
  Internet
  Hardware
  Media
  Software
  Telecommunications

Tel: 0086-10-82600828
Fax: 0086-10-82601570
Email:


 Novartis - Worst Performing Pharmaceutical
 
CreateTime:2011-09-07 Editor:lile
Text Size:       
 

New York, September 6th (TradersHuddle.com) - The market ended the trading session lower with the S&P 500 losing 0.74%. Stocks of Pharmaceutical Companies also traded lower, with NYSE Drug index ending the trading session at 306.53, which represents -0.21% versus the previous tradings session close. The Drug index was mixed with 8 out of 15 components trading higher.

The sector's top performer today was Pfizer (NYSE:PFE) closing the trading session at $18.65 representing 1.03%. versus the previous trading session price action. Pfizer, the pharmaceutical company maker of Viagra and Lipitor, shares have defined support at $17.50 and resistance at $19.15.

JNJ (NYSE:JNJ) was also among the top performers, closing the trading session at $64.64 representing 0.89% from its previous close. JNJ, the consumer health care products company maker of Tylenol and Sudafed has calculated support and resistance levels at $59.08 and $66.23 respectively. The other top performer was Bristol-Myers Squibb (NYSE:BMY), which closed the trading session at $29.24 representing 0.79% from the previous trading session.

The sector's worst performer today was Novartis (NYSE:NVS) that closed the trading session at $55.94 or -2.37% from the previous close. Novartis, the Basel, Switzerland based pharmaceutical company shares have defined support at $52.09 and resistance at $59.25. Also among the worst performers was Teva (NASDAQ:TEVA), which closed the trading session at $39.36 representing -2.16% from the previous trading session.


Related Reports
China Vacuum Blood Collection Device Industry Report, 2019-2025
China Human Vaccine Industry Report, 2019-2025
China Independent Clinical Laboratory Industry Report, 2019-2025
Global and China Monoclonal Antibody Industry Report, 2019-2025
China Contract Research Organization (CRO) Industry Report, 20...
2005-2010 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1